Navigation Links
A New Diagnostic Approach To Pediatric Interstitial Lung Disease

Chronic interstitial lung disease (ILD) comprises a large, heterogeneous group of rare pulmonary disorders //characterized by diffuse infiltrates, restrictive lung disease, and abnormal gas exchange with considerable mortality and morbidity. ILD presents enormous diagnostic challenges because the differential diagnosis includes more than 100 conditions in both adults2 and children.

Researchers from Texas and Colorado conducted a descriptive, observational study was to evaluate the value of a systematic approach to the diagnosis of pediatric ILD. The study appears in the journal Pediatrics (vol. 101). In this prospective study, the researchers evaluated 51 children presenting with ILD of unknown etiology during a 3-year period. Specific clinical information regarding history, physical examination, diagnostic evaluation, and final diagnosis was recorded on each patient.

A specific diagnosis was established by history and physical examination alone in 1 patient, noninvasive tests alone in 8 others, and invasive tests, including lung biopsy, in another 26. Of the remaining patients, 8 had a suggestive diagnosis, and 8 had no specific diagnosis.

In this study, all of the patients who did not have ITs are currently living, whereas all of the deaths or tranplant occurred in patients who had had ITs. Although the series was small, this observation suggests that the algorithm was utilized appropriately, reserving the most invasive studies for the sickest patients.

In conclusion, this study demonstrates that pediatric ILD comprises a heterogeneous group of mostly rare disorders that present tremendous diagnostic challenges. A systematic approach to the diagnosis of pediatric ILD is useful, and not all patients need lung biopsy for diagnosis.

The authors stress that a systematic evaluation will preclude the need for invasive tests in some patients. Although this series is one of the largest to be reported in ch ildren, the study suffers from small numbers relative to those reported for adult ILD. Because no single pediatric center can see large numbers of pediatric ILD patients, multi center collaboration will be required to extend these observations.

Medindia on Lung cancer:

Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all people who smoke get lung cancer. And, some people who have never smoked get lung cancer. Normal lung tissue is made up of cells that are programmed by nature to create lungs of a certain shape and function.
'"/>




Related medicine news :

1. Cancer Risk From Exposure To Diagnostic X-Rays
2. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
3. Schizophrenia Gets A New Diagnostic Tool
4. Diagnostic Procedure For Tuberculosis Made Easy
5. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
6. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
7. Diagnostic Centre Inaugurated for Air Pollution at SRMC
8. Lab Tests And Diagnostics - Next Wave Of Outsourcing
9. New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders
10. eGFR Diagnostic Test -A reliable and understandable measure of kidney impairment
11. Obesity Hinders Medical Diagnostic Tests
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... ... , ... Doctor C LLC, a company based out of Arizona that focuses ... the marketing and distribution of its product, The Right C. , The Right C ... than traditional vitamin C supplements. At the trade show, Doctor C had the opportunity ...
(Date:1/20/2017)... ... 20, 2017 , ... ATP Science, an Australian-based company focused ... the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding meetings ... of supplements that keep the body functioning at its peak performance by providing ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... , January 19, 2017 ... Otsuka in the Milner Therapeutics Consortium   ... in Cambridge   ... PFE ) as a partner to the ... Consortium, which enables the efficient transfer of materials between ...
Breaking Medicine Technology: